Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
16th week of 2017 patent applcation highlights part 7
Patent application number
Title
Published
20170105929
BIODEGRADABLE NANOPARTICLES AS NOVEL HEMOGLOBIN-BASED OXYGEN CARRIERS AND METHODS OF USING THE SAME
2017-04-20
20170105930
AQUEOUS OPHTHALMIC SOLUTION OF OLOPATADINE
2017-04-20
20170105931
PHARMACEUTICAL COMPOSITIONS COMPRISING GELS AND METHODS FOR FABRICATING THEREOF
2017-04-20
20170105932
INTRAOCULAR DRUG DELIVERY DEVICE AND ASSOCIATED METHODS
2017-04-20
20170105933
Suppression of Undesired 18 FDG Uptake within inflammatory lymph nodes and inflamed tissues on Positron Emission Tomography Scans that are obtained for Neoplastic Staging
2017-04-20
20170105934
AQUEOUS OPHTHALMIC COMPOSITION
2017-04-20
20170105935
PHARMACEUTICAL COMPOSITION CAPABLE OF ACCELERATED PENETRATION INTO AFFECTED AREA
2017-04-20
20170105936
LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF
2017-04-20
20170105937
OLAPARIB CO-PRECIPITATE AND PREPARATION METHOD THEREOF
2017-04-20
20170105938
COMPOSITIONS AND METHODS FOR DELIVERY OF OMEPRAZOLE PLUS ACETYLSALICYLIC ACID
2017-04-20
20170105939
EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS OF LEVETIRACETAM
2017-04-20
20170105940
COATING AGENT FOR SOLID PREPARATION, AND FILM AND COATED SOLID PREPARATION FORMED THEREWITH
2017-04-20
20170105941
NANOPARTICULATE COMPLEX OF NICOTINE AND CERIUM OXIDE AND USE THEREOF
2017-04-20
20170105942
TASTE-MASKED PHARMACEUTICAL COMPOSITIONS WITH GASTROSOLUBLE PORE-FORMERS
2017-04-20
20170105943
COMPOSITION FOR PROMOTION OF WOUND HEALING
2017-04-20
20170105944
ONCE-A-DAY REPLACEMENT TRANSDERMAL ADMINISTRATION OF FENTANYL
2017-04-20
20170105945
Transdermal Delivery System Containing Rotigotine
2017-04-20
20170105947
Appetite Suppressant Composition
2017-04-20
20170105948
NUTRITIONAL COMPOSITIONS FOR MODULATING INFLAMMATION INCLUDING EXOGENOUS VITAMIN K2
2017-04-20
20170105949
METHOD FOR IMPROVING FEED EFFICIENCY IN RUMINANTS
2017-04-20
20170105950
ELECTROSTATICALLY CHARGED NASAL APPLICATION METHOD AND PRODUCT FOR MICRO-FILTRATION
2017-04-20
20170105951
COMBINATION THERAPY WITH THIOCOLCHICINE DERIVATIVES
2017-04-20
20170105952
HISTONE ACETYL TRANSFERASE ACTIVATORS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF ALCOHOLISM
2017-04-20
20170105953
METHOD FOR SUPPRESSING DIABETES AND/OR HEPATIC LIPIDS USING TORMENTIC ACID
2017-04-20
20170105954
ACTIVATION OF AMP-PROTEIN ACTIVATED KINASE BY OXALOACETATE COMPOUNDS
2017-04-20
20170105955
LIQUID PHARMACEUTICAL FORMULATIONS OF TETRAIODOTHYRONINE
2017-04-20
20170105956
NOVEL METHODS OF TREATING OR PREVENTING FIBROTIC LUNG DISEASES
2017-04-20
20170105957
Methods of Treating Ototoxicity
2017-04-20
20170105958
USE OF A FEED COMPOSITION FOR REDUCING METHANE EMISSION IN RUMINANTS, AND/OR TO IMPROVE RUMINANT PERFORMANCE
2017-04-20
20170105960
Prodrugs of Succinic Acid for Increasing ATP Production
2017-04-20
20170105961
Novel Cell-Permeable Succinate Compounds
2017-04-20
20170105962
PHARMACEUTICAL COMPOSITION COMPRISING OMEGA-(ARYLSULFONYL)ALKYLNITRILE
2017-04-20
20170105963
SMALL MOLECULES THAT INDUCE INTRINSIC PATHWAYS APOPTOSIS
2017-04-20
20170105964
METHODS AND COMPOSITIONS FOR THE MODULATION OF BETA-ENDORPHIN LEVELS
2017-04-20
20170105965
PPAR-gamma ACTIVATOR
2017-04-20
20170105966
PHARMACEUTICAL COMPOSITION CONTAINING INDOMETACIN AND/OR ACEMETACIN
2017-04-20
20170105967
COMPOSITIONS AND METHODS OF TREATMENT OF INFLAMMATORY SKIN CONDITIONS USING ALLANTOIN
2017-04-20
20170105968
Compositions and Methods for Treatment of Inflammatory Skin Conditions Using Allantoin
2017-04-20
20170105969
CENICRIVIROC FOR THE TREATMENT OF HIV-2 INFECTION
2017-04-20
20170105970
ONDANSETRON SUBLINGUAL SPRAY FORMULATION
2017-04-20
20170105971
METHODS AND COMPOUNDS FOR THE TREATMENT OF BONE LOSS AND/OR PAIN
2017-04-20
20170105972
SOFT CHEWABLE PHARMACEUTICAL PRODUCTS
2017-04-20
20170105973
SOLID DISPERSIONS OF INSOLUBLE DRUG AND PREPARATION METHOD THEREOF
2017-04-20
20170105974
USE OF MTOR INHIBITORS FOR PREVENTION OF INTESTINAL POLYP GROWTH AND CANCER
2017-04-20
20170105975
THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF
2017-04-20
20170105976
THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF
2017-04-20
20170105977
METHODS FOR RETREATING IRRITABLE BOWEL SYNDROME (IBS)
2017-04-20
20170105978
NEW COMPOUNDS
2017-04-20
20170105979
USE OF A TORASEMIDE-BASED VETERINARY COMPOSITION FOR LOW-DOSE ADMINISTERING
2017-04-20
20170105980
Methods For Treating Nicotinic Acetylcholine Receptor Associated Diseases
2017-04-20
20170105981
METHODS FOR STABILIZING HYPOXIA INDUCIBLE FACTOR-2 ALPHA AS A METHOD FOR TREATING CANCER
2017-04-20
20170105982
COMPOSITIONS AND METHODS FOR TREATMENT OF LUNG DYSFUNCTION
2017-04-20
20170105983
COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS
2017-04-20
20170105984
CANCER STEM CELL PROLIFERATION INHIBITOR AND INTRACELLULAR ACTIVE OXYGEN ACCUMULATION INDUCER
2017-04-20
20170105985
NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ATTENTION DEFICIT DISORDER AND 22Q SYNDROME
2017-04-20
20170105986
Topical Formulation to Enhance Genital Sensation and Function
2017-04-20
20170105987
Formulations and Methods for Treating High Intraocular Pressure
2017-04-20
20170105988
Pharmaceutical Compositions Comprising Levocetirizine
2017-04-20
20170105989
COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
2017-04-20
20170105990
CRYSTALLINE FORMS OF TYROSINE KINASE INHIBITORS AND THEIR SALTS
2017-04-20
20170105991
FOAMABLE OTIC PHARMACEUTICAL COMPOSITIONS
2017-04-20
20170105992
ORAL VETERINARY PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS
2017-04-20
20170105993
HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS
2017-04-20
20170105994
CERTAIN PROTEIN KINASE INHIBITORS
2017-04-20
20170105995
BIOMARKERS OF RESPONSE TO NAE INHIBITORS
2017-04-20
20170105996
TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE OR NON-ALCOHOLIC STEATOHEPATITIS WITH DELAYED-RELEASE 6-MERCAPTOPURINE
2017-04-20
20170105997
METHODS OF TREATING CANCER
2017-04-20
20170105998
METABOLICALLY-ACTIVATED DRUG CONJUGATES TO OVERCOME RESISTANCE IN CANCER THERAPY
2017-04-20
20170105999
METHOD FOR TREATING DRUG RESISTANT CANCER
2017-04-20
20170106000
A PALLADIUM COMPLEX WITH HIGH ANTICANCER ACTIVITY
2017-04-20
20170106001
METHODS AND MATERIALS FOR REDUCING SUPRESSION OF IMMUNE FUNCTION
2017-04-20
20170106002
ORAL TESTOSTERONE ESTER FORMULATIONS AND METHODS OF TREATING TESTOSTERONE DEFICIENCY COMPRISING SAME
2017-04-20
20170106003
ANTI-CANCER EFFECTS OF JAK2 INHIBITORS IN COMBINATION WITH THALIDOMIDE DERIVATIVES AND GLUCOCORTICOIDS
2017-04-20
20170106004
Nutritional Intervention for Improving Muscular Function and Strength
2017-04-20
20170106005
TREATING CONDITIONS ASSOCIATED WITH INCREASED EOTAXIN WITH 25-HYDROXYVITAMIN D3
2017-04-20
20170106006
Neuroprotection by Mitochondria-Targeted Metformin
2017-04-20
20170106007
COMPOSITIONS AND METHODS RELATING TO TREATMENT OF INFECTION
2017-04-20
20170106008
STAT5a AND ITS FUNCTIONAL TUMOR SUPPRESSOR ANALOGS FOR TREATMENT OF MALIGNANCIES EXPRESSING NPM/ALK AND OTHER ONCOGENIC KINASES
2017-04-20
20170106009
METHODS OF TREATING DISEASES
2017-04-20
20170106010
P-ETHOXY NUCLEIC ACIDS FOR LIPOSOMAL FORMULATION
2017-04-20
20170106011
METHODS OF TREATING TRAUMATIC BRAIN INJURY AND SEQUELAE
2017-04-20
20170106012
Glycosaminoglycans
2017-04-20
20170106013
BIOPHOTONIC HYDROGELS
2017-04-20
20170106014
SYSTEMS AND METHODS FOR TREATMENT OF ACNE VULGARIS AND OTHER CONDITIONS WITH A TOPICAL NITRIC OXIDE DELIVERY SYSTEM
2017-04-20
20170106015
ARTICLE OF APPAREL FOR TOPICAL DELIVERY OF BIORESORBABLE MATERIAL
2017-04-20
20170106016
MAGNESIUM COMPOSITIONS AND USES THEREOF FOR NEUROLOGICAL DISORDERS
2017-04-20
20170106017
METHODS AND COMPOSITIONS FOR TREATMENT OF MACROPHAGE-RELATED DISORDERS
2017-04-20
20170106018
PHARMACEUTICAL COMPOSITIONS COMPRISING FERRIC CITRATE AND METHODS FOR THE PRODUCTION THEREOF
2017-04-20
20170106019
COMPOSITIONS AND METHODS FOR MITIGATING DRUG RESISTANT BACTERIA
2017-04-20
20170106020
ANESTHETIC/ANALGESIC COMPOSITION
2017-04-20
20170106021
COMPOSITIONS ENRICHED FOR HOX11+ STEM CELLS AND METHODS OF PREPARING THE SAME
2017-04-20
20170106022
ASSAYS FOR DETERMINING THE EFFECT OF AN IMMUNE CELL ON A CELL FROM AN INFECTIOUS OR NEOPLASTIC DISEASE
2017-04-20
20170106023
TREATMENT OF IMMUNE DISORDERS
2017-04-20
20170106024
Methods For Treating Age-Related Organ Or Tissue Dysfunction Through Heterochronic Transbiosis Using Nonviable Pluripotent Stem Cells
2017-04-20
20170106025
Method and System for Treating Gastro-Esophageal Reflux Disease (GERD)
2017-04-20
20170106026
Method and System for Treating Non-Alcoholic Fatty Liver Disease
2017-04-20
20170106027
COMPOSITIONS AND METHODS OF IMPROVING PERFORMANCE AND INTESTINAL HEALTH OF POULTRY
2017-04-20
20170106028
AGENT FOR INDUCING INTERFERON PRODUCTION CONTAINING LACTIC ACID BACTERIA
2017-04-20
20170106029
COMPOSITION AND METHOD FOR MAINTAINING HEALTHY KIDNEY FUNCTION
2017-04-20
20170106030
Extraction of cannabidiol
2017-04-20